Clinical Trial Update: NIOX VERO Nasal Application in Primary Ciliary Dyskinesia

View source ↗

Summary

A completed clinical trial evaluated the NIOX VERO nasal application for primary ciliary dyskinesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ciliary Dyskinesia

Drugs mentioned

• NIOX VERO

Snippet

Sponsor: Aerocrine AB | Conditions: PCD | Status: COMPLETED